Safety and feasibility of a balloon-based pulsed field ablation system for the catheter ablation of paroxysmal atrial fibrillation
Journal of Interventional Cardiac Electrophysiology · 19.08.2026 · 69 (9) · 3025-3032
DOI: 10.1007/s10840-026-02417-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, online erschienen am 19.08.2026. Verfasst von Peize Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: TEDA International Cardiovascular Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Foundation of Tianjin Binhai New Area Health Commission, Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
AIMS: Pulsed field ablation (PFA) is a ablation modality that is increasingly used for pulmonary vein isolation (PVI) in atrial fibrillation (AF) patients. This study assessed the safety and effectiveness of a balloon-based PFA system at 6 months after treatment. METHODS AND RESULTS: This study is a prospective, single-center, premarket study. A total of 56 patients with drug-refractory paroxysmal atrial fibrillation (PAF) were enrolled between November 2024 and September 2025 and underwent PVI with a balloon-based PFA system. The study endpoints were the rate of primary serious adverse events, acute procedural effectiveness and 6-month freedom from recurrence. Acute effectiveness was achieved in 100% (231/231) of the treated PVs (100% of patients, 56/56), with 33 ± 5.5 PFA applications/patient. The procedure, fluoroscopy, and transpired ablation times were 89.0 ± 30.7, 24.2 ± 8.3, and 20.0 ± 12.0 min, respectively. One (1.8%; 1/56) primary serious adverse event occurred: one patient developed intraoperative gastrointestinal bleeding due to TEE-induced mechanical injury. One patient developed a cerebral infarction on postoperative Day 28. The rate of freedom from documented atrial arrhythmias was 92.9% through 6 months after the index procedure. CONCLUSION: The primary results of this study demonstrate the safety and effectiveness of the balloon-based PFA system for performing PVI in patients with PAF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TEDA International Cardiovascular Hospital, Tianjin, China.
- TEDA International Cardiovascular Hospital, Tianjin, China. 33757883@qq.com.
Förderung
- Science Foundation of Tianjin Binhai New Area Health Commission
- Tianjin Key Medical Discipline Construction Project
Zitieren
APA
Wang, P., Zhang, K., Bai, J., Dong, X., Yang, S., Tian, L., Zhang, Z., Li, Z., Miao, Y., & Liu, J. (2026). Safety and feasibility of a balloon-based pulsed field ablation system for the catheter ablation of paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 69(9), 3025-3032. https://doi.org/10.1007/s10840-026-02417-4
Vancouver
Wang P, Zhang K, Bai J, Dong X, Yang S, Tian L, et al. Safety and feasibility of a balloon-based pulsed field ablation system for the catheter ablation of paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2026;69(9):3025-3032. doi:10.1007/s10840-026-02417-4
BibTeX
@article{Wang2026,
author = {Wang, Peize and Zhang, Kun and Bai, Jinlong and Dong, Xiuhong and Yang, Shuai and Tian, Lichao and Zhang, Zhaoqian and Li, Zhi and Miao, Yuhao and Liu, Jingjing},
title = {Safety and feasibility of a balloon-based pulsed field ablation system for the catheter ablation of paroxysmal atrial fibrillation},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2026},
volume = {69},
number = {9},
pages = {3025--3032},
doi = {10.1007/s10840-026-02417-4}
}
EUVIMED